THE ROTHBURY PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: A84002 | MORPETH, NE65 7RW
Showing results 101-150 of 525
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Fluticasone/umeclidinium/vilanterol | 261 | 335 | £14.2K | +11.3% ▲ |
| Glyceryl trinitrate | 259 | 375 | £659 | +9.5% ▲ |
| Quetiapine | 256 | 8,239 | £2.2K | -58.9% ▼ |
| Diltiazem hydrochloride | 254 | 16.3K | £3.2K | -17.3% ▼ |
| Umeclidinium bromide/vilanterol | 251 | 279 | £8.6K | +28.7% ▲ |
| Isosorbide mononitrate | 243 | 22.1K | £1.4K | -63.2% ▼ |
| Esomeprazole | 242 | 14.0K | £1.2K | -40.2% ▼ |
| Loratadine | 240 | 9,489 | £206 | +14.9% ▲ |
| Lamotrigine | 239 | 24.6K | £1.5K | -59.5% ▼ |
| Trimethoprim | 237 | 7,128 | £389 | +16.0% ▲ |
| Solifenacin | 236 | 11.0K | £534 | -50.5% ▼ |
| Sulfasalazine | 232 | 46.8K | £7.9K | +78.2% ▲ |
| Eplerenone | 227 | 9,604 | £1.2K | -14.4% ▼ |
| Clobetasone butyrate | 220 | 11.2K | £2.2K | +7.8% ▲ |
| Sumatriptan succinate | 213 | 2,566 | £3.0K | -39.9% ▼ |
| Ranolazine | 209 | 16.3K | £3.0K | +23.0% ▲ |
| Dorzolamide and timolol | 207 | 4,025 | £3.3K | +44.6% ▲ |
| Diazepam | 206 | 7,262 | £154 | -58.6% ▼ |
| Sodium valproate | 205 | 27.0K | £3.7K | -35.5% ▼ |
| Letrozole | 205 | 10.7K | £953 | +9.8% ▲ |
| Thiamine hydrochloride | 200 | 12.2K | £392 | -62.1% ▼ |
| Spironolactone | 196 | 9,632 | £542 | -63.6% ▼ |
| Cyclizine hydrochloride | 196 | 8,263 | £294 | +21.5% ▲ |
| Desogestrel | 196 | 28.6K | £1.3K | -50.6% ▼ |
| Aciclovir | 195 | 11.4K | £499 | +31.1% ▲ |
| Famotidine | 193 | 8,811 | £5.0K | -60.4% ▼ |
| Insulin aspart | 192 | 1,055 | £7.4K | -49.6% ▼ |
| Oxycodone hydrochloride | 190 | 20.2K | £2.4K | -25.8% ▼ |
| Ispaghula husk | 178 | 9,947 | £1.7K | +35.1% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 177 | 16.3K | £669 | -42.2% ▼ |
| Quinine sulfate | 174 | 6,944 | £1.0K | -39.9% ▼ |
| Timolol and bimatoprost | 171 | 921 | £2.5K | +12.7% ▲ |
| Edoxaban | 167 | 6,888 | £11.5K | -76.2% ▼ |
| Hyoscine butylbromide | 165 | 17.8K | £1.3K | -29.2% ▼ |
| Co-codamol (Codeine phosphate/paracetamol) | 165 | 20.7K | £840 | -91.6% ▼ |
| Ferrous fumarate | 164 | 10.0K | £388 | -77.4% ▼ |
| Oxybutynin | 160 | 18.7K | £3.3K | -16.0% ▼ |
| Levetiracetam | 158 | 15.5K | £1.1K | -65.5% ▼ |
| Memantine hydrochloride | 158 | 4,114 | £395 | -52.2% ▼ |
| Methylprednisolone acetate | 154 | 164 | £578 | +33.4% ▲ |
| Azithromycin | 153 | 3,548 | £881 | +20.7% ▲ |
| Biphasic isophane insulin | 151 | 1,673 | £6.9K | +35.3% ▲ |
| Mometasone furoate | 151 | 219 | £1.7K | -62.4% ▼ |
| Tiotropium bromide | 144 | 4,604 | £6.2K | -52.6% ▼ |
| Clobetasol propionate | 141 | 7,215 | £594 | +3.3% ▲ |
| Combined ethinylestradiol 30mcg | 138 | 13.9K | £1.1K | -50.3% ▼ |
| Mesalazine (Systemic) | 136 | 21.1K | £8.1K | -43.2% ▼ |
| Fluticasone furoate | 135 | 152 | £1.2K | -30.3% ▼ |
| Mebeverine hydrochloride | 134 | 13.2K | £442 | -56.8% ▼ |
| Carbamazepine | 128 | 12.9K | £1.1K | -56.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.